506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL)
The purpose of this study is to determine whether Nelarabine is effective in the treatment of patients with T-ALL/NHL in order to achieve a complete remission followed by an early stem cell transplantation.
T-ALL, T-NHL (Lymphoblastic)
DRUG: Nelarabine
Tolerability and Efficacy of Compound GW506U78 in relapsed/refractory T-ALL/NHL, after 1 cycle and 2 cycles
The purpose of this study is to determine whether Nelarabine is effective in the treatment of patients with T-ALL/NHL in order to achieve a complete remission followed by an early stem cell transplantation.